YK-11

---

← Previous: xipamide | 🏠 All Substances | 📊 Complete Table | Next: zaleplon →

---

Other names:

• YK-11-OA
• 19-norpregna-4,20-diene-21-carboxylic acid, 17,20-((1-methoxyethylidene)bis(oxy))-3-oxo-, methyl ester, (17alpha,20E)-
• methyl(2E)-2-[(8R,9S,10R,13S,14S,17R)-2’-methoxy-2’,13-dimethyl-3-0x0spiro[1,2,6.7,8,9,10,11,12,14,15,16-dodecahydroyclopenta[
• 19-norpregna-4,20-diene-21-carboxylic acid, 17,20-((1-methoxyethylidene)bis(oxy))-3-oxo-, methyl ester, (17α,20E)-
• YK-500
• (17-α,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3- oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester)
• 17α,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene- 21-carboxylic acid methyl ester
• YK11 cpd
• (17a,20E)-17,20-[(1-Methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester
• YK11
• YK 11

Classifications:

• 6000

Reasons for prohibition:

• WADA S1: Anabolic Agents (WADA Prohibited List S1: Anabolic Agents)
• Unapproved Drug
• FDA Statement

References:

• NIH NCATS Inxight Drugs entry: YK-11
• FDA warns against using SARMs in body-building products

More info: Not specified

Source of: Not specified

Reason: WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs

Label terms: Not specified

Linked ingredients: Not specified

Searchable name: yk-11

GUID: abf7848f-3428-4117-a0b8-5a4c578d4a3f

Added to this Database: 2025-12-30T21:42:08.769789+00:00

Last updated in source database: 2024-07-12T18:11:05

---

📊 Complete Table | 🏠 All Substances

Substance 872 of 880